Mark Bachleda - 28 Feb 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Commercial Officer
Signature
/s/ Chris Degnan, Attorney-in-Fact for Mark J. Bachleda
Issuer symbol
GRTX
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 15:05:43 UTC
Previous filing
12 Oct 2021
Next filing
28 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 28 Feb 2022 Common Stock 75,000 $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.